Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Nanotheranostics 2024; 8(3):380-400. doi:10.7150/ntno.87818 This issue Cite

Review

Knockout cancer by nano-delivered immunotherapy using perfusion-aided scaffold-based tumor-on-a-chip

Pooja Suryavanshi1,2, Dhananjay Bodas1,2,✉

1. Nanobioscience Group, Agharkar Research Institute, G.G. Agarkar Road, Pune 411 004 India.
2. Savitribai Phule Pune University, Ganeshkhind Road, Pune 411 007 India.

✉ Corresponding author: Email: dsbodasorg.

Citation:
Suryavanshi P, Bodas D. Knockout cancer by nano-delivered immunotherapy using perfusion-aided scaffold-based tumor-on-a-chip. Nanotheranostics 2024; 8(3):380-400. doi:10.7150/ntno.87818. https://www.ntno.org/v08p0380.htm
Other styles

File import instruction

Abstract

Graphic abstract

Cancer is a multifactorial disease produced by mutations in the oncogenes and tumor suppressor genes, which result in uncontrolled cell proliferation and resistance to cell death. Cancer progresses due to the escape of altered cells from immune monitoring, which is facilitated by the tumor's mutual interaction with its microenvironment. Understanding the mechanisms involved in immune surveillance evasion and the significance of the tumor microenvironment might thus aid in developing improved therapies. Although in vivo models are commonly utilized, they could be better for time, cost, and ethical concerns. As a result, it is critical to replicate an in vivo model and recreate the cellular and tissue-level functionalities. A 3D cell culture, which gives a 3D architecture similar to that found in vivo, is an appropriate model.

Furthermore, numerous cell types can be cocultured, establishing cellular interactions between TME and tumor cells. Moreover, microfluidics perfusion can provide precision flow rates, thus simulating tissue/organ function. Immunotherapy can be used with the perfused 3D cell culture technique to help develop successful therapeutics. Immunotherapy employing nano delivery can target the spot and silence the responsible genes, ensuring treatment effectiveness while minimizing adverse effects. This study focuses on the importance of 3D cell culture in understanding the pathophysiology of 3D tumors and TME, the function of TME in drug resistance, tumor progression, and the development of advanced anticancer therapies for high-throughput drug screening.

Keywords: 3D cell culture, microfluidics, perfusion, multicellular tumor, in vitro immunotherapy

Citation styles

APA
Suryavanshi, P., Bodas, D. (2024). Knockout cancer by nano-delivered immunotherapy using perfusion-aided scaffold-based tumor-on-a-chip. Nanotheranostics, 8(3), 380-400. https://doi.org/10.7150/ntno.87818.

ACS
Suryavanshi, P.; Bodas, D. Knockout cancer by nano-delivered immunotherapy using perfusion-aided scaffold-based tumor-on-a-chip. Nanotheranostics 2024, 8 (3), 380-400. DOI: 10.7150/ntno.87818.

NLM
Suryavanshi P, Bodas D. Knockout cancer by nano-delivered immunotherapy using perfusion-aided scaffold-based tumor-on-a-chip. Nanotheranostics 2024; 8(3):380-400. doi:10.7150/ntno.87818. https://www.ntno.org/v08p0380.htm

CSE
Suryavanshi P, Bodas D. 2024. Knockout cancer by nano-delivered immunotherapy using perfusion-aided scaffold-based tumor-on-a-chip. Nanotheranostics. 8(3):380-400.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use